Ophthalmology · Yorktown Heights, NY
NPI
1275549552
Since 2006
Specialty
Ophthalmology
Code 207W00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
3535 Hill Blvd Ste R
Yorktown Heights, NY, 10598
Phone (914) 245-3303
Groups this clinician bills Medicare through
Medicare paid, 2024
$540K
4,576 services
Medicare patients, 2024
1,172
Average age 75
Drug cost, 2024
$420K
2,526 prescriptions
Company payments, 2025
$1,796
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Kayvan Keyhani was code 92136 (ultrasound - nonspecific), 587 times for 429 patients. In total Kayvan Keyhani billed 4,576 services in 66 codes, and Medicare paid $540K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-03-29.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 92136 Ultrasound - Nonspecific | Office | 587 | 429 | $35.08 | $21K |
| 99214 Office E&M - Established | Office | 482 | 464 | $111.84 | $54K |
| 92134 Computerized Ophthalmic Imaging | Office | 445 | 417 | $36.59 | $16K |
| 66984 Cataract Surgery | Facility | 330 | 219 | $471.71 | $156K |
| 92014 Ophthalmological E&M | Office | 328 | 315 | $103.99 | $34K |
| 99213 Office E&M - Established | Office | 238 | 194 | $81.47 | $19K |
| 92250 Angiography | Office | 157 | 157 | $32.27 | $5,067 |
| 92285 Standard X-ray | Office | 156 | 151 | $22.29 | $3,477 |
| 92083 Vision, Hearing, and Speech Services | Office | 136 | 125 | $58.44 | $7,948 |
| 66982 Cataract Surgery | Facility | 134 | 100 | $673.45 | $90K |
| 99203 Office E&M - New | Office | 118 | 118 | $94.95 | $11K |
| 92201 Ophthalmological E&M | Office | 114 | 113 | $21.99 | $2,506 |
| 92133 Computerized Ophthalmic Imaging | Office | 109 | 94 | $31.15 | $3,395 |
| 92020 Ophthalmological E&M | Office | 97 | 97 | $25.44 | $2,467 |
| 99204 Office E&M - New | Office | 74 | 74 | $140.29 | $10K |
By year: 2022 $522K for 5,399 services; 2023 $522K for 4,502 services; 2024 $540K for 4,576 services.
Medicare prescription drug claims, 2024
In 2024, the drug Kayvan Keyhani prescribed most often to Medicare patients was Prednisolone Acetate, with 757 prescriptions and refills. In total Kayvan Keyhani wrote 2,526 Medicare prescriptions that cost $420K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 757 | 790 | 465 | $38K |
| Gatifloxacin Generic | 570 | 570 | 342 | $23K |
| Prolensa Bromfenac Sodium | 329 | 346 | 202 | $113K |
| Latanoprost Generic | 265 | 622 | 95 | $3,479 |
| Ofloxacin Generic | 132 | 134 | 89 | $1,529 |
| Bromfenac Sodium Generic | 63 | 67 | 43 | $11K |
| Erythromycin Erythromycin Base | 52 | 52 | 49 | $570 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 39 | 87 | 13 | $1,115 |
| Restasis Cyclosporine | 31 | 81 | 18 | $48K |
| Vyzulta Latanoprostene Bunod | 30 | 66 | 14 | $19K |
| Simbrinza Brinzolamide/Brimonidine Tart | 25 | 49 | 14 | $6,272 |
| Tobramycin-Dexamethasone Tobramycin/Dexamethasone | 22 | 23 | 21 | $1,007 |
| Fluorometholone Generic | 19 | 19 | 18 | $1,377 |
| Timolol Maleate Generic | 19 | 56 | Under 11 | $521 |
| Xiidra Lifitegrast | 18 | 32 | Under 11 | $21K |
Brand drugs: 1,418 claims; generic drugs: 1,108 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Kayvan Keyhani $1,796 ($1,796 in general payments such as food, travel and fees) from 11 companies. The largest payer was Bausch & Lomb Americas Inc. with $425.
| Company | Payments | Amount |
|---|---|---|
| Bausch & Lomb Americas Inc. BLCO | 13 | $425 |
| Alcon Vision LLC ALC | 13 | $343 |
| Tarsus Pharmaceuticals, Inc. TARS | 4 | $216 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 3 | $202 |
| RxSight Inc RXST | 3 | $164 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 5 | $137 |
| Mallinckrodt Hospital Products Inc. | 4 | $107 |
| Oyster Point Pharma, Inc. | 2 | $53.24 |
| Amgen Inc. AMGN | 2 | $50.59 |
| Biotissue Holdings Inc. | 2 | $48.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.